Literature DB >> 16669672

New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.

Barry M Trost1, Guangbin Dong.   

Abstract

New classes of nucleophiles, pyrroles, and N-methoxyamides were developed for Pd-catalyzed AAA reactions. By varying the functional groups at the 2-position of pyrroles, either regioisomer of the piperazinone is available. Using one regioisomer, the total synthesis of (+)-agelastatin A in 10 total steps is accomplished. For this synthesis, a new copper-catalyzed aziridination and an indium-catalyzed oxidative ring opening of a N-tosylaziridine were developed. The feasibility of accessing (-)-agelastatin A from the same enantiomer of the chiral catalyst from the other regioisomeric piperazinone is indicated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16669672      PMCID: PMC2585983          DOI: 10.1021/ja061105q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  11 in total

Review 1.  Marine natural products.

Authors:  D John Faulkner
Journal:  Nat Prod Rep       Date:  2002-02       Impact factor: 13.423

2.  Asymmetric transition-metal-catalyzed allylic alkylations: applications in total synthesis.

Authors:  Barry M Trost; Matthew L Crawley
Journal:  Chem Rev       Date:  2003-08       Impact factor: 60.622

3.  New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.

Authors:  Mathias M Domostoj; Ed Irving; Feodor Scheinmann; Karl J Hale
Journal:  Org Lett       Date:  2004-07-22       Impact factor: 6.005

Review 4.  Natural guanidine derivatives.

Authors:  Roberto G S Berlinck; Miriam H Kossuga
Journal:  Nat Prod Rep       Date:  2005-07-04       Impact factor: 13.423

5.  Agelastatins C and D, new pentacyclic bromopyrroles from the sponge Cymbastela sp., and potent arthropod toxicity of (-)-agelastatin A.

Authors:  T W Hong; D R Jímenez; T F Molinski
Journal:  J Nat Prod       Date:  1998-01       Impact factor: 4.050

Review 6.  Pd asymmetric allylic alkylation (AAA). A powerful synthetic tool.

Authors:  Barry M Trost
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-01       Impact factor: 1.645

7.  Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent.

Authors:  L Meijer; A M Thunnissen; A W White; M Garnier; M Nikolic; L H Tsai; J Walter; K E Cleverley; P C Salinas; Y Z Wu; J Biernat; E M Mandelkow; S H Kim; G R Pettit
Journal:  Chem Biol       Date:  2000-01

8.  Asymmetric total synthesis of (-)-agelastatin a using sulfinimine (N-sulfinyl imine) derived methodologies.

Authors:  Franklin A Davis; Jianghe Deng
Journal:  Org Lett       Date:  2005-02-17       Impact factor: 6.005

9.  Complete control of the chemoselectivity in catalytic carbene transfer reactions from ethyl diazoacetate: an N-heterocyclic carbene-Cu system that suppresses diazo coupling.

Authors:  Manuel R Fructos; Tomás R Belderrain; M Carmen Nicasio; Steven P Nolan; Harneet Kaur; M Mar Díaz-Requejo; Pedro J Pérez
Journal:  J Am Chem Soc       Date:  2004-09-08       Impact factor: 15.419

10.  Alkynyliodonium salts in organic synthesis. Application to the total synthesis of (-)-agelastatin A and (-)-agelastatin B.

Authors:  Ken S Feldman; Joe C Saunders
Journal:  J Am Chem Soc       Date:  2002-08-07       Impact factor: 15.419

View more
  24 in total

1.  Palladium-catalyzed asymmetric allylic alkylation of electron-deficient pyrroles with meso electrophiles.

Authors:  Barry M Trost; Maksim Osipov; Guangbin Dong
Journal:  Org Lett       Date:  2012-04-16       Impact factor: 6.005

2.  Pd and Mo Catalyzed Asymmetric Allylic Alkylation.

Authors:  Barry M Trost
Journal:  Org Process Res Dev       Date:  2012-01-13       Impact factor: 3.317

3.  A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.

Authors:  Paul M Wehn; J Du Bois
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

4.  Development of a concise synthesis of (-)-oseltamivir (Tamiflu).

Authors:  Barry M Trost; Ting Zhang
Journal:  Chemistry       Date:  2011-03-01       Impact factor: 5.236

5.  Syntheses of Cyclic Guanidine-Containing Natural Products.

Authors:  Yuyong Ma; Saptarshi De; Chuo Chen
Journal:  Tetrahedron       Date:  2015-02-25       Impact factor: 2.457

6.  Bioinspired total synthesis of agelastatin A.

Authors:  Jeremy Chris P Reyes; Daniel Romo
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-11       Impact factor: 15.336

7.  Synthesis and anti-HIV activity of new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems.

Authors:  Takeshi Sakamoto; Matthew D Cullen; Tracy L Hartman; Karen M Watson; Robert W Buckheit; Christophe Pannecouque; Erik De Clercq; Mark Cushman
Journal:  J Med Chem       Date:  2007-06-19       Impact factor: 7.446

8.  A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin A.

Authors:  Barry M Trost; Guangbin Dong
Journal:  Chemistry       Date:  2009-07-13       Impact factor: 5.236

9.  Total synthesis of (+/-)-agelastatin A, a potent inhibitor of osteopontin-mediated neoplastic transformations.

Authors:  David P Dickson; Duncan J Wardrop
Journal:  Org Lett       Date:  2009-03-19       Impact factor: 6.005

Review 10.  A submarine journey: the pyrrole-imidazole alkaloids.

Authors:  Barbara Forte; Beatrice Malgesini; Claudia Piutti; Francesca Quartieri; Alessandra Scolaro; Gianluca Papeo
Journal:  Mar Drugs       Date:  2009-11-27       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.